Letrozole

CHEMBL1444 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
285.3 g/mol
LogP
2.7
Phase
4

A nonsteroidal aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women, and studied in other hormone-sensitive conditions. It works by blocking estrogen production to deprive cancer cells of the hormone they need to grow.

Peso molecular

285,3000 g/mol

LogP

2,70

TPSA

78,30 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1

InChI

InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H

Molecular Formula

C17H11N5

HBD / HBA

- / 4

Enlaces Rotables

3

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A nonsteroidal aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women, and studied in other hormone-sensitive conditions. It works by blocking estrogen production to deprive cancer cells of the hormone they need to grow.

Yes, Letrozole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1444. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3902. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.